Jiangsu Aoyang Health Industry Co.ltd. (SHE:002172)

China · Delayed Price · Currency is CNY

3.090

+0.110 (3.69%)

Jul 27, 2026, 1:55 PM CST

SHE:002172 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	1,761	1,807	2,010	2,174	2,021	1,429
Revenue Growth	-6.32%	-10.10%	-7.54%	7.54%	41.41%	-24.18%
Gross Profit	229.1	247.23	264.64	289.06	280.15	440.06
Operating Income	68.09	82.91	87.49	85.58	115.17	-13.82
Net Income	28.03	41.29	40.56	49.68	-15.37	-1,039
Earnings Per Share	0.04	0.05	0.05	0.06	-0.02	-1.34
EPS Growth	16.00%	0%	-16.67%	-	-	-

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Medical Division	974.02
Pharmaceutical Division	1,134
Offset of Business Segment	-301.13
Total	1,807

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	314.44	405.8	521.49	707.37	984.16	1,036
Total Debt	808.3	880.14	1,002	1,219	1,465	2,179
Net Cash (Debt)	-493.86	-474.33	-480.69	-511.82	-481.21	-1,144
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.68	-0.57	-0.59	-0.62	-0.63	-1.48

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	224.4	12.62	0.44	54.3	-33.8	-33.47
Capital Expenditures	-21.25	-32.58	-28.64	-63.59	-193.17	-221.12
Free Cash Flow	203.14	-19.96	-28.2	-9.29	-226.97	-254.58
Free Cash Flow Growth	28128.96%	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	13.01%	13.68%	13.17%	13.30%	13.86%	30.79%
Operating Margin	3.87%	4.59%	4.35%	3.94%	5.70%	-0.97%
Pretax Margin	2.46%	3.30%	3.24%	3.22%	-0.05%	-58.73%
Profit Margin	1.59%	2.28%	2.02%	2.29%	-0.76%	-72.68%
FCF Margin	11.53%	-1.10%	-1.40%	-0.43%	-11.23%	-17.81%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	77.14	73.62	59.09	58.41	-	-
Forward PE	-	16.05	16.05	16.05	16.05	16.05
PS Ratio	1.30	1.68	1.19	1.34	1.57	2.16